GGrantIndex
Sort

326,823 grants matching clinical trial

SCCOR in Cardiac Dysfunction and Disease

$3,251,049
Louis Joseph Dell'italia · University Of Alabama At Birmingham · P50 · FY2007 · HL

Novel Medication Approaches for Substance Abuse

$3,250,717
Herbert David Kleber · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P50 · FY2013 · DA

Reagent Program for HIV and other Infectious Diseases

$3,250,651
Sujatha Rashid · American Type Culture Collection · N01 · FY2021 · AI

Terry Beirn CPCRA Clinical Trials Unit

$3,249,978
Fred M Gordin · George Washington University · UM1 · FY2014 · AI

Colorado Clinical and Transational Sciences Institute

$3,249,905
Ronald J Sokol · University Of Colorado Denver · UL1 · FY2021 · TR

Alliance for Clinical Trials in Oncology Operations Center

$3,249,644
Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2018 · CA

Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU

$3,249,397
Daniel R Kuritzkes · Massachusetts General Hospital · U01 · FY2011 · AI

Development of ITI-333, a μ-opioid Receptor Partial Agonist and 5HT2A and D1 Receptor Antagonist, for the Treatment of Opioid Use Disorders

$3,249,130
Gretchen L Snyder · Intra-Cellular Therapies, Inc. · UG3 · FY2019 · DA

UCSD Alzheimer's Disease Research Centers P30

$3,248,425
James B Brewer · University Of California, San Diego · P30 · FY2021 · AG

Reagent Program for HIV and other Infectious Diseases

$3,248,336
Sujatha Rashid · American Type Culture Collection · N01 · FY2022 · AI

Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)

$3,248,075
Kenneth E Palmer · University Of Louisville · U19 · FY2016 · AI

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)

$3,247,921
Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2013 · AI

The Four Repeat Tauopathy Neuroimaging Initiative

$3,247,823
Adam L Boxer · University Of California, San Francisco · R01 · FY2016 · AG

HPV Vaccine Trials

$3,246,839
Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Integrating Addiction Research in Health Systems: The Addiction Research Network

$3,246,804
Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2019 · DA

Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE

$3,246,560
Tracy A Glauser · Cincinnati Childrens Hosp Med Ctr · U01 · FY2010 · NS

Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)

$3,246,233
Kevin Navin Sheth · Yale University · U01 · FY2020 · NS

Vaccine Induced Immunity in the Young and Aged

$3,245,387
Rafi Ahmed · Emory University · U19 · FY2015 · AI

Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids

$3,244,725
Michael Parks Bogenschutz · New York University School Of Medicine · UG3 · FY2024 · DA

SCORE2 Comparative Trial (SCT)

$3,243,882
Ingrid U Scott · Pennsylvania State Univ Hershey Med Ctr · U10 · FY2013 · EY

Alabama Clinical Trials Unit

$3,243,756
Edgar T Overton · University Of Alabama At Birmingham · UM1 · FY2019 · AI

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study

$3,243,500
Kimberly Lee Drews · George Washington University · U01 · FY2015 · DK

COG NCTN Network Group Operations Center - Year 10 STAR Act COG) Outcomes & Survivorship (LTE) Committee

$3,243,049
Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA

Southern Consortium Node of the Clinical Trials Network

$3,243,031
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2019 · DA

A fully-implanted spinal cord stimulation system to restore sensation and relieve phantom limb pain after lower-limb amputation

$3,242,520
Lee E Fisher · University Of Pittsburgh At Pittsburgh · UG3 · FY2025 · NS